The efficacy of curcumin-piperine co-supplementation on clinical symptoms, duration, severity, and inflammatory factors in COVID-19 outpatients: a randomized double-blind, placebo-controlled trial

Peer Review reports

Original Submission
29 Aug 2021	Submitted	Original manuscript
16 Mar 2022	Reviewed	Reviewer Report - Seyed Ali Keshavarz
18 Mar 2022	Reviewed	Reviewer Report - Sayyed Saeid Khayyatzadeh
24 Mar 2022	Reviewed	Reviewer Report - Emad Yuzbashian
22 Apr 2022	Author responded	Author comments - Gholamreza Askari
Resubmission - Version 2
22 Apr 2022	Submitted	Manuscript version 2
28 Apr 2022	Reviewed	Reviewer Report - Emad Yuzbashian
28 Apr 2022	Reviewed	Reviewer Report - Seyed Ali Keshavarz
1 May 2022	Reviewed	Reviewer Report - Sayyed Saeid Khayyatzadeh
Resubmission - Version 3
	Submitted	Manuscript version 3
Publishing
2 May 2022	Editorially accepted
6 Jun 2022	Article published	10.1186/s13063-022-06375-w

Back to article page